Last Updated on January 6, 2024 by The Health Master
Illegal Drug Factory
In a significant operation, the Food and Drugs Administration (FDA) Haryana and Police Department joined forces to bust an illegal drug factory located in Ambala Cantt, Haryana.
The FDA Haryana team comprises Sunil Dahiya, Senior Drugs Control Officer, Ambala, and Hemant Grover, Drugs Control Officer, Ambala.
The timely intervention prevented a suspect from escaping, ensuring that justice would be served.
The meticulous efforts of the FDA Haryana team have resulted in the confiscation of crucial evidence, including samples of both drugs and chemicals.
Unearthing the Illicit Factory
The illegal drug factory, operating under the name “Walt Pharma,” was discreetly nestled in the Defense Colony Sector-C of Ambala Cantt.
Authorities had received credible information suggesting that the factory was producing supplements without adhering to the established regulations.
Remarkably, it was discovered that the owner of the facility also ran a gym, utilizing it as a front to distribute these illicit supplements to unsuspecting gym-goers.
Swift Action and Thorough Investigation
The joint team of the FDA Haryana and Police Department swiftly mobilized to Ambala Cantt to quell this nefarious operation.
Upon arrival, they found themselves in a race against time, as a person present at the factory attempted to flee the scene.
However, the vigilant police managed to apprehend the individual, ensuring that justice would prevail.
With the suspect in custody, the FDA Haryana team proceeded to meticulously comb through every inch of the factory.
This thorough search was a crucial step in gathering comprehensive evidence against the illicit operation.
Samples of drugs and chemicals were carefully collected, providing invaluable proof of the factory’s illegal activities.
Crucial Records Under Scrutiny
Simultaneously, the FDA Haryana team began a meticulous examination of the factory’s records.
This step is vital in tracing the extent of the illegal operation, as well as identifying any potential accomplices or individuals involved in the distribution network.
By scrutinizing these records, authorities aim to dismantle the entire operation, ensuring that justice is served to the fullest extent of the law.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Jan Vishwas Act: Transforming Penalties for Drug Advertising Offenses
USFDA approval granted for this inflammatory bowel disease drug
USFDA issues Form 483 with 9 observation to Dr Reddy’s laboratories: Hyderabad
Regulatory Changes: Relief for Class C and D Medical Device in India
Govt Job: Unlocking Opportunities for CDSCO Recruitment 2023
Understanding the New Price Regulations for Orthopaedic Knee Implants: NPPA
Drug recall: These injections recalled due to Glass Particulate Matter
IPC: Indian Pharmacopoeia Commission joins the Pharmacopoeial Discussion Group
USFDA issues Form 483 with one observation to Aurobindo Unit IV: Andhra Pradesh
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
